Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study)
NCT04508855 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2024-07-30
Summary
The primary objective is to assess the safety and efficacy of switching from direct oral anticoagulants to low molecular weight heparin in cancer patients during antineoplastic therapy
Conditions
Interventions
- DRUG
-
Low molecular weight heparin
Switch from direct oral anticoagulants to low molecular weight heparin
Sponsors & Collaborators
-
Theagenio Cancer Hospital
collaborator OTHER_GOV -
AHEPA University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-01
- Primary Completion
- 2023-08-31
- Completion
- 2023-12-31
Countries
- Greece
Study Locations
More Related Trials
-
Study of Proteins in Head and Neck Cancer Cells
NCT00896948 ·Status: COMPLETED
-
Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH
NCT02552381 ·Status: COMPLETED
-
Prognostic Markers for a Better Follow-up in Head and Neck Cancer.
NCT06094985 ·Status: RECRUITING
-
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
NCT01187173 ·Status: COMPLETED
-
Prospective and Retrospective Cohort Study to Find New Prognostic Factors and Therapeutic Targets in Patients With Newly Diagnosed or Relapsed Malignant Hematologic Disorder Excluding Acute Leukemia
NCT02330718 ·Status: UNKNOWN
-
Precision Medicine for Patients With Identified Actionable Mutations
NCT04111107 ·Status: TERMINATED ·Phase: PHASE2
-
Molecular and Genomic Profiling of Head and Neck Tumors
NCT00200486 ·Status: RECRUITING
-
Registry of the German CLL Study Group
NCT02863692 ·Status: RECRUITING
-
Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck
NCT00002695 ·Status: COMPLETED
-
Hereditary Risk Factors for Thyroid Cancer
NCT02747888 ·Status: RECRUITING ·Phase: NA
-
Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
NCT01109420 ·Status: RECRUITING
-
Prospective Sinonasal Cancer Multi-institution Study
NCT04755855 ·Status: RECRUITING
-
Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules
NCT03392402 ·Status: COMPLETED
-
Analysis of Circulating Tumor Markers in Blood
NCT04025541 ·Status: RECRUITING ·Phase: NA
-
Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia
NCT01500499 ·Status: COMPLETED
-
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
NCT00230308 ·Status: RECRUITING
-
Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma
NCT00981097 ·Status: COMPLETED
-
Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in NHL Patients
NCT03079947 ·Status: UNKNOWN
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·Status: RECRUITING
-
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
NCT00026663 ·Status: COMPLETED
-
Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms
NCT01390597 ·Status: COMPLETED
-
Screening Study for Participants With Malignant Tumors
NCT05419375 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarker Research for Personalized Medicine
NCT01488591 ·Status: UNKNOWN
-
Genetic Testing in Young Adults With Cancer Study
NCT04533555 ·Status: COMPLETED ·Phase: NA
-
CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth
NCT05405413 ·Status: RECRUITING ·Phase: PHASE2